Reduction of accelerated failures by transfusion.
D000961:Antilymphocyte Serum / Q000276:immunology; D001803:Blood Transfusion; D006082:Graft Enhancement, Immunologic; D006084:Graft Rejection; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007108:Immune Tolerance; D007668:Kidney / Q000276:immunology; D016030:Kidney Transplantation; D013997:Time Factors
D000961:Antilymphocyte Serum; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II